Biotech company BeiGene renames and relocates to Basel
Select your language
Generated with artificial intelligence.
Listening:
Biotech company BeiGene renames and relocates to Basel
The international biotechnology company BeiGene is moving its legal headquarters from the Cayman Islands to Basel. In addition, the company, which specialises in cancer therapies, is now officially changing its name to BeOne Medicines, as the company announced on Tuesday.
+Get the most important news from Switzerland in your inbox
With the relocation of its headquarters, BeOne joins other large publicly traded research-based pharmaceutical companies based in Switzerland, Roche and Novartis.
Founded in 2010, the oncology company employs almost 11,000 people worldwide. The company, which is based in Cambridge in the US and Beijing, also set up shop in Basel in 2018. It opened its European headquarters there four years later.
+ Chinese biotechs eye Swiss collaboration as relations with US sour
The company started in Basel with 3 employees and now has 265, with the aim of further improving the treatment of blood cancer and solid tumours, according to the press release.
“I am delighted that we have succeeded in attracting BeOne Medicines, an innovative global oncology company, to Basel,” commented Basel’s Director of Economic Affairs Kaspar Sutter (SP) in the press release. This relocation emphasises the company’s strong commitment to the region and strengthens Basel’s status “as one of the leading life science clusters in Europe”.
Translated from German by DeepL/jdp
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.